Navigation Links
Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators
Date:5/18/2009

ons as an instructor in medicine at Harvard Medical School and assistant in medicine at Massachusetts General Hospital. His postdoctoral training includes a fellowship in hematology and oncology at Dana-Farber/Partners and an internship and residency in Internal Medicine at Massachusetts General Hospital. Dr. Multani received his M.S. in clinical epidemiology from Harvard School of Public Health, his M.D. from Harvard Medical School, and he graduated summa cum laude from Yale University with a B.S. in chemistry and biology.

About Fate Therapeutics, Inc.

Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem (iPS) cell technology to develop Stem Cell Modulators (SCMs), small molecule or biologic compounds that guide cell fate for therapeutic purposes. Fate's approach has broad therapeutic potential in areas such as regenerative medicine, hematological diseases, metastatic cancer, traumatic injury and degenerative diseases. The Company's first therapeutic candidate is scheduled to enter clinical trials in early 2009 in hematopoietic stem cell support. In addition, Fate Therapeutics and Stemgent have formed an alliance - Catalyst - a collaborative program to provide its partners with first access to the most advanced induced pluripotent stem (iPS) cell technologies for drug discovery and development. Fate Therapeutics is headquartered in La Jolla, CA. For more information, please visit http://www.fatetherapeutics.com.

Fate Therapeutics along with Stemgent, Genzyme, Burrill & Company and WIRED Magazine, will be featured in a panel presentation entitled "Mastering Your (Cell) Fate: Stem Cells, iPSCs and t
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference
2. Nile Therapeutics Reports 2009 First Quarter Financial Results
3. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
4. Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results
5. Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
6. Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
7. Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2009 Financial Results on Wednesday, May 13th, at 4:30 P.M. EST
8. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants
9. Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
10. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
11. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "My ... sleep knowing that, at any moment, her fever might ... order to keep me well aware of how she ... developed the TEMP ALARM to continuously monitor a child's ... develops a fever. This ensures that prompt medical care ...
(Date:8/30/2014)... August 30, 2014 Serving contented clients ... India, Profit By Outsourcing is now offering discount ... The company gives emphasize on putting forward the best ... to clients. Their dedicated team of professionals and web ... They can handle even the critical issues of web ...
(Date:8/30/2014)... Bringing forth the great opportunities, India's #1 ... Day discount on all SEO services. While working with ... related to internet marketing. Their dedicated team of professionals ... have a deep understanding for their specialization. This further ... since the inception, they have worked with over 5000 ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The ... mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston ... sever four cases selected for one of the ... on August 18, 2014, U.S. District Judge Joseph ... Virginia disagrees with Boston Scientific’s contention that a ...
(Date:8/30/2014)... "I had a handicapped friend who could not ... inventor from Wetumpka, Ala. "In order to help her be ... I came up with a way for her to use ... for the patent-pending Deezers to allow crutches to be used ... crutches, walkers, or canes at the beach. The device reduces ...
Breaking Medicine News(10 mins):Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3
... As world health leaders work vigorously to consider ... Consumer Specialty Products Association says taking simple precautions can ... something everyone should take seriously," said Chris Cathcart, CSPA ... to keep themselves and their families healthy now and ...
... A West Australian research team has made the world-first ... Liar, that leads other molecules into the nucleus of ... prostate, breast and colon cancers as well as leukemia. ... Australian Institute for Medical Research (WAIMR) led by Associate ...
... Ashley Koff R.D. helps Americans find healthier choices--BEVERLY HILLS, ... proud to announce Ashley Koff Approved (AKA), the unbiased ... several years of hearing her clients, medical colleagues, and ... recognized as a trusted source in the world of ...
... Spiderman Mulholland, one of the country,s leading forensic ... mold, is conducting investigations and working with environmental ... issues that have impacted homes and buildings in ... to date points to sulfur emissions that corrode ...
... reports show Google lobbied on the electronic medical ... contradicting the Internet giant,s earlier claims that Consumer ... false."Google,s report shows a total expenditure of $880,000 ... health-related initiatives; issues relating to online personal health ...
... system to reduce , workload, improve patient care, minimize ... Vocantas Inc., a developer of automated telephone outreach solutions, ... The Ottawa Hospital to manage patients in its Thrombosis ... in the Canadian Medical Association Journal shows that CallAssure ...
Cached Medicine News:Health News:Swine Influenza Outbreak - How to Stay Healthy 2Health News:WA discovery a key to blood cell development 2Health News:Introducing 'Ashley Koff Approved' (AKA): the Stamp of Nutrition for Optimal Health 2Health News:Forensic Expert Investigating Chinese Drywall Issue 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 3Health News:Award-winning partnership proves Vocantas CallAssure effective tool for chronic disease management 2Health News:Award-winning partnership proves Vocantas CallAssure effective tool for chronic disease management 3Health News:Award-winning partnership proves Vocantas CallAssure effective tool for chronic disease management 4
(Date:8/29/2014)... -- Market Research Report on Global and Chinese ... and in-depth market survey on Global and ... firstly reviews the basic information of X-Ray Crystallography ... The report then explores global and China,s top ... specification, capacity, Production value, and market share etc. ...
(Date:8/29/2014)... ANGELES , Aug. 29, 2014  Chuma ... both financing alternatives and turnkey support services for ... announce that FINRA processed and approved the Company,s ... 29, 2014, CannaMed Corporation will be known as ... change was accomplished through a merger with the ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... Biosciences announced,today, the initiation of a Phase 2 ... management of acute infectious,mononucleosis. Currently, there are no ... or any other disease caused by,the Epstein-Barr virus ... of anti-viral activity,including inhibition of viral replication of ...
... Dec. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... ), has begun a Phase 1 clinical trial of ... R343,for the treatment of allergic asthma. R343 is the ... terms of the companies, 2005 collaboration agreement, Rigel,will receive ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
Provides extended cold therapy to the shoulder area for acute, chronic, or post-surgical applications. The DuraKold products can help reduce pain, edema, and speed recovery....
Provides continuous cold therapy to the knee area for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and facilitate faster rehabilitation....
... The Philadelphia® Halo™ was designed in 1988 ... applied to the patient, it greatly restricts rotation ... patient recovers, the Halo can be removed while ... ,May be used in conjunction with the ...
... and cold therapy Gel Pad. Our Gel Pad ... therapy to reduce swelling and /or hot therapy ... ,To order hot and cold therapy gel pad, ... ,Our suspenders can be added to each support ...
Medicine Products: